IP Library Granted Patent US 8,945,363
Granted Patent B2
US 8,945,363 · App. 12/539,028 · Granted Feb 3, 2015

Method of making metal implants

Inventors: Martin Edward Lee Pickford (Southampton, GB); Andrew Derek Turner (Abingdon, GB)
Assignee: Accentus Medical Limited
A61L27/306C25D11/26A61F2/30767A61L27/04A61F2/3094A61F2/32A61F2002/30929A61F2002/30967A61F2310/00017A61F2310/00023A61F2310/00029A61F2310/00089A61F2310/0052A61F2310/00592A61F2310/00598A61F2310/00796
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,363
App. No.
12/539,028
Granted
Feb 3, 2015
Kind
B2
Abstract

A metal implant for use in a surgical procedure is provided with a surface layer that is integral with the metal substrate, and which incorporates a biocidal material. The surface layer may be grown from the metal substrate, by anodizing, and the biocidal material incorporated in it by ion exchange. Alternatively the layer may be deposited by electroplating, followed by diffusion bonding so as to become integral with the metal substrate. In either case, silver is a suitable biocidal material; and both the release rate and the quantity of biocidal material should be low to avoid toxic effects on body cells. Electropolishing the surface before formation of the surface layer is also beneficial, and this may be achieved by electropolishing.

Claims (22)

1. A method of making an implant for use in a surgical procedure, the implant comprising a metal substrate, wherein the metal substrate is of a titanium alloy or zirconium, and wherein the implant comprises an anodised surface layer containing biocidal metal ions absorbed by ion exchange, such that, after implantation, leaching of the biocidal metal ions kills bacteria in the vicinity of the implant and suppresses infection, and the method comprising the successive steps of:

(A) forming a surface layer on the substrate which is integral with the metal substrate by growing the layer by an anodising process that is carried out using a solution of phosphoric acid, wherein the surface layer comprises a phosphate;

(B) rinsing the surface layer on the substrate; and

(C) contacting the surface layer on the substrate with a solution that contains biocidal metal ions, so as to absorb biocidal metal ions by ion exchange into the surface layer, thereby forming a phosphate comprising at least one biocidal metal ion, wherein after contacting with the solution that contains biocidal metal ions, the implant is ready to be implanted.

2. A method as claimed in claim 1 wherein the biocidal metal ions are selected from the group consisting of silver, copper, palladium, platinum and ruthenium.

3. A method as claimed in claim 2 wherein the biocidal metal ions are of silver.

4. A method as claimed in claim 3 wherein the solution is an aqueous silver nitrate solution.

5. A method as claimed in claim 3 wherein the concentration of silver ions absorbed in the surface layer is equivalent to an average surface loading of 73 micrograms/cm 2 .

6. A method as claimed in claim 1 comprising the step of polishing the implant to provide a smooth surface before forming the surface layer.

7. A method as claimed in claim 6 wherein the polishing subjects the implant to a combination of anodic passivation with mechanical polishing.

8. A method as claimed in claim 1 wherein the implant is anodised for 2 hours at a maximum voltage of 10 V and a maximum current of 10 mA/cm 2 , to form the surface layer.

9. A method of making an implant for use in a surgical procedure, the implant comprising a metal substrate, wherein the metal substrate is of a titanium alloy or zirconium, and wherein the implant comprises an anodised surface layer containing biocidal metal ions absorbed by ion exchange, such that after implantation leaching of the biocidal metal ions kills bacteria in the vicinity of the implant and suppresses infection, and the method consists essentially of the successive steps of:

(A) forming a surface layer on the substrate which is integral with the metal substrate by growing the layer by an anodising process that is carried out using a solution of phosphoric acid, wherein the surface layer comprises a phosphate;

(B) rinsing the surface layer on the substrate; and

(C) contacting the surface layer on the substrate with a solution that contains biocidal metal ions, so as to absorb biocidal metal ions by ion exchange into the surface layer, thereby forming a phosphate comprising at least one biocidal metal ion, wherein after contacting with the solution that contains biocidal metal ions, the implant is ready to be implanted.

10. A method as claimed in claim 9 wherein the biocidal metal ions are selected from the group consisting of silver, copper, palladium, platinum and ruthenium.

11. A method as claimed in claim 10 wherein the biocidal metal ions are of silver.

12. A method as claimed in claim 11 wherein the concentration of silver ions absorbed in the surface layer is equivalent to an average surface loading of 73 micrograms/cm 2 .

13. A method as claimed in claim 11 wherein the solution is an aqueous silver nitrate solution.

14. A method as claimed in claim 9 comprising the step of polishing the implant to provide a smooth surface before forming the surface layer.

15. A method as claimed in claim 14 wherein the polishing subjects the implant to a combination of anodic passivation with mechanical polishing.

16. A method as claimed in claim 9 wherein the implant is anodised for 2 hours at a maximum voltage of 10 V and a maximum current of 10 mA/cm 2 , to form the surface layer.

Assignments (3)
CHANGE OF NAME Recorded Dec 3, 2014
From: ACCENTUS PLC
To: ACCENTUS MEDICAL PLC
Reel/Frame 034364/0675 →
CHANGE OF NAME Recorded Dec 3, 2014
From: ACCENTUS MEDICAL PLC
To: ACCENTUS MEDICAL LIMITED
Reel/Frame 034524/0975 →
EXCLUSIVE LICENSE AGREEMENT Recorded Jun 26, 2013
From: ACCENTUS MEDICAL PLC
To: ZIMMER, INC.
Reel/Frame 030710/0423 →
Priority Claims (1)
GB 0208642.9 · Apr 16, 2002 · national
Continuity (2)
Division 10501538
Related Publication 20100032309A1 · Feb 11, 2010